Golden Cross Stocks — Financial View · Biological Products, (No Diagnostic Substances)
5 stocks match the Golden Cross Stocks screen. Stocks whose 50-day moving average has just crossed above their 200-day — a classic bullish trend signal. Financial columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| GILD | Gilead Sciences | $187.5B | 2.1% | -6.6% | -27.4% | -8.5% | 1.27 | 2.22 | 79.6% | -8.2% | -10.6% | 151.21 | +1.09% | 186K |
| CRSP | Crispr Therapeutics Ag | $5.5B | — | -17.0% | -25.8% | -19.3% | 17.85 | 0.34 | — | — | — | 56.47 | -0.79% | 71K |
| NVAX | Novavax Inc | $1.7B | — | -25.9% | — | — | 2.33 | -1.53 | 29.0% | -20.8% | -22.1% | 10.34 | +0.19% | 229K |
| ZURA | Zura Bio Ltd | $563M | — | -40.2% | -43.5% | -43.5% | 12.90 | 0.08 | — | — | — | 5.88 | +3.52% | 81K |
| LIMN | Liminatus Pharma, Inc. | $248M | — | — | — | — | 1.12 | 10.32 | — | — | — | 3.70 | -2.89% | 293 |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.